Tenofovir therapy is associated with increased urinary phosphate excretion and decreased bone mineral density in patients with chronic hepatitis B

被引：0
|
作者：
Le, S. [1 ,2 ]
Wong, P. [3 ,4 ,5 ]
Shochet, I. [6 ]
Doyle, A. [1 ]
Shelton, E. [1 ]
Milat, F. [3 ,4 ,5 ]
Sievert, W. [1 ,2 ]
机构：
[1] Monash Hlth, Dept Gastroenterol & Hepatol, Clayton, Vic 3168, Australia
[2] Monash Univ, Ctr Inflammatory Dis, Clayton, Vic 3168, Australia
[3] Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia
[4] Monash Hlth, Dept Endocrinol, Clayton, Vic 3168, Australia
[5] Monash Univ, Dept Med, Southern Clin Sch, Clayton, Vic 3168, Australia
[6] Monash Hlth, Dept Gen Med, Clayton, Vic 3168, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2013年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：161 / 161
页数：1
相关论文
共 50 条
  • [31] Tenofovir-associated nephrotoxicity in patients with chronic hepatitis B: two cases
    Cho, Hyeki
    Cho, Yuri
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Oh, Kook-Hwan
    Lee, Kyoungbun
    Mustika, Syifa
    Yoon, Jung-Hwan
    Kim, Yoon Jun
    CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (02) : 286 - 291
  • [32] Factors Associated with Decreased Bone Mineral Density in Patients with Crohn's Disease
    Rita, Barreto Maria
    Daniela, Magro
    Michel, Camargo
    Augusto, Martinez Carlos
    Bruno, Geloneze
    de Lourdes, Ayrizono Maria
    Jose, Pareja
    Jose, Saad Mario
    Claudio, Coy
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S11 - S12
  • [33] Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia
    Gerstner, G.
    Damiano, M. L.
    Tom, A.
    Worman, C.
    Schultz, W.
    Recht, M.
    Stopeck, A. T.
    HAEMOPHILIA, 2009, 15 (02) : 559 - 565
  • [34] A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir
    Huang, Pao-Yuan
    Chiu, Sherry Yueh-Hsia
    Chang, Kuo-Chin
    Tseng, Po-Lin
    Yen, Yi-Hao
    Tsai, Ming-Chao
    Wang, Jing-Houng
    Kee, Kwong-Ming
    Chen, Chien-Hung
    Hung, Chao-Hung
    Chiu, King-Wah
    Hu, Tsung-Hui
    HEPATOLOGY INTERNATIONAL, 2021, 15 (02) : 310 - 317
  • [35] A novel evidence of serial changes of bone mineral density in chronic hepatitis B patients treated with entecavir
    Pao-Yuan Huang
    Sherry Yueh-Hsia Chiu
    Kuo-Chin Chang
    Po-Lin Tseng
    Yi-Hao Yen
    Ming-Chao Tsai
    Jing-Houng Wang
    Kwong-Ming Kee
    Chien-Hung Chen
    Chao-Hung Hung
    King-Wah Chiu
    Tsung-Hui Hu
    Hepatology International, 2021, 15 : 310 - 317
  • [36] Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection
    Gracey, David M.
    Snelling, Paul
    McKenzie, Paul
    Strasser, Simone I.
    ANTIVIRAL THERAPY, 2013, 18 (07) : 945 - 948
  • [37] Fatal Lactic Acidosis Associated With Tenofovir Therapy for Chronic Active Hepatitis B Infection
    Mckeever, Rita
    Surmaitis, Ryan
    Vearrier, David
    Greenberg, Michael
    CLINICAL TOXICOLOGY, 2016, 54 (08) : 745 - 745
  • [38] Increased Serum Osteoprotegerin Levels Associated with Decreased Bone Mineral Density in Familial Mediterranean Fever
    Yuksel, Seref
    Samli, Hale
    Colbay, Mehmet
    Dundar, Umit
    Acarturk, Gursel
    Demir, Serap
    Koken, Tulay
    Aktepe, Orhan Cem
    Kavuncu, Vural
    Solak, Mustafa
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 217 (04): : 321 - 327
  • [39] Tenofovir alafenamide significantly increased serum lipid levels compared with entecavir therapy in chronic hepatitis B virus patients
    Lai, Rui-Min
    Lin, Shan
    Wang, Miao-Miao
    Li, Na
    Zhou, Jia-Hui
    Lin, Xiao-Yu
    Chen, Tian-Bin
    Zhu, Yue-Yong
    Zheng, Qi
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (08) : 964 - 972
  • [40] Association between gastric polyps and decreased bone mineral density in patients with chronic gastritis
    Liu, Guotao
    Zhang, Jianyuan
    SCIENTIFIC REPORTS, 2025, 15 (01):
12345